miR-668 enhances the radioresistance of human breast cancer cell by targeting IκBα

miR-668 enhances the radioresistance of human breast cancer cell by targeting IκBα Breast Cancer (2017) 24:673–682 DOI 10.1007/s12282-017-0756-1 ORIGINAL ARTICLE miR-668 enhances the radioresistance of human breast cancer cell by targeting IjBa 1,2 1,2 1,2 1,2,3 • • • Ming Luo Ling Ding Qingjian Li Herui Yao Received: 5 September 2016 / Accepted: 18 January 2017 / Published online: 30 January 2017 The Japanese Breast Cancer Society 2017 Abstract IjBa expression, suppressed NF-jB, increased radiosen- Background A large proportion of breast cancer patients sitivity of MCF-7R and T-47DR cells. are resistant to radiotherapy, which is a mainstay treatment Conclusion Our findings suggest miR-668 is involved in for this malignancy, but the mechanisms of radioresistance the radioresistance of breast cancer cells and miR-668- remain unclear. IjBa-NF-jB axis may be a novel candidate for developing Methods and materials To evaluate the role of miRNAs in rational therapeutic strategies for human breast cancer radioresistance, we established two radioresistant breast treatment. cancer cell lines MCF-7R and T-47DR derived from par- ental MCF-7 and T-47D. Moreover, miRNA microarray, Keywords miR-668  Radioresistance  Breast cancer quantitative RT-PCR analysis, luciferase reporter assay and IjBa  NF-jB western blotting were used. Results We found that miR-668 was most abundantly expressed in radioresistant cells MCF-7R and T-47DR. Introduction miR-668 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Breast Cancer Springer Journals

miR-668 enhances the radioresistance of human breast cancer cell by targeting IκBα

Loading next page...
 
/lp/springer_journal/mir-668-enhances-the-radioresistance-of-human-breast-cancer-cell-by-jEKAxbz0y6
Publisher
Springer Japan
Copyright
Copyright © 2017 by The Japanese Breast Cancer Society
Subject
Medicine & Public Health; Surgical Oncology; Oncology; Surgery; Cancer Research
ISSN
1340-6868
eISSN
1880-4233
D.O.I.
10.1007/s12282-017-0756-1
Publisher site
See Article on Publisher Site

Abstract

Breast Cancer (2017) 24:673–682 DOI 10.1007/s12282-017-0756-1 ORIGINAL ARTICLE miR-668 enhances the radioresistance of human breast cancer cell by targeting IjBa 1,2 1,2 1,2 1,2,3 • • • Ming Luo Ling Ding Qingjian Li Herui Yao Received: 5 September 2016 / Accepted: 18 January 2017 / Published online: 30 January 2017 The Japanese Breast Cancer Society 2017 Abstract IjBa expression, suppressed NF-jB, increased radiosen- Background A large proportion of breast cancer patients sitivity of MCF-7R and T-47DR cells. are resistant to radiotherapy, which is a mainstay treatment Conclusion Our findings suggest miR-668 is involved in for this malignancy, but the mechanisms of radioresistance the radioresistance of breast cancer cells and miR-668- remain unclear. IjBa-NF-jB axis may be a novel candidate for developing Methods and materials To evaluate the role of miRNAs in rational therapeutic strategies for human breast cancer radioresistance, we established two radioresistant breast treatment. cancer cell lines MCF-7R and T-47DR derived from par- ental MCF-7 and T-47D. Moreover, miRNA microarray, Keywords miR-668  Radioresistance  Breast cancer quantitative RT-PCR analysis, luciferase reporter assay and IjBa  NF-jB western blotting were used. Results We found that miR-668 was most abundantly expressed in radioresistant cells MCF-7R and T-47DR. Introduction miR-668

Journal

Breast CancerSpringer Journals

Published: Jan 30, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off